Using the Rapid Cycle Performance Improvement (RCPI) model this course will assist you in planning and implementing a performance improvement project in your practice.

Faculty: Nicholas S. Hill, MD
Reviewer: Robin J. Trupp PhD, APRN, FAHA

Recorded Live:
Monday, December 21, 2009

Please review this page completely before starting this course. Links to the course options can be found at the bottom of this page.

• Identify measures for assessing your practice performance in the diagnosis of patients suspected of pulmonary arterial hypertension (PAH)

• Write an AIM statement to be used for performance improvement

• Develop an Improvement Plan for diagnosing PAH

• Initiate an RCPI project for PAH in your practice

MEBN's mission is to provide medical education that is accurate, fair-balanced, unbiased and evidence-based. MEBN strives to ensure that every educational activity maintains independence, objectivity and scientific rigor. All faculty participating in these activities are expected to disclose any (or no) relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of these relationship(s) will be listed prior to any educational activity.

All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation. Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

Continuing Medical Education for Physicians

Accreditation Statement

MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credits

MEBN designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FDA Disclosure Statement

The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Accreditation Period

Release Date: December 31, 2009 End Date: December 31, 2011

Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net)

Continuing Education for Nurses
MEBN is an approved provider of continuing nursing education by the New Hampshire Nurses’ Association Commission on Continuing Education, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. MEBN recognizes that the accredited status refers only to our continuing nursing education activities and does not imply that the ANCC Commission on Accreditation approves or endorses these commercial products.

Contact Hours
MEBN designates this continuing education activity for up to 0.75 contact hour(s) of nursing continuing education credit.

Accreditation Period
Release Date: December 31, 2009
End Date: December 31, 2011

This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.